Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Macha MA, Rachagani S, Qazi AK, Jahan R, Gupta S, Patel A, Seshacharyulu P, Lin C, Li S, Wang S, Verma V, Kishida S, Kishida M, Nakamura N, Kibe T, Lydiatt WM, Smith RB, Ganti AK, Jones DT, Batra SK, Jain M.
Macha MA, et al.
Oncotarget. 2017 Mar 28;8(13):20961-20973. doi: 10.18632/oncotarget.15468.
Oncotarget. 2017.
PMID: 28423495
Free PMC article.